Recognizing November 8, 2025, as Premenstrual Dysphoric Disorder Awareness Day.

89(R) HR 1298 - Enrolled version - Bill Text

H.R. No. 1298

R E S O L U T I O N

WHEREAS, The observance of Premenstrual Dysphoric Disorder

Awareness Day on November 8, 2025, provides a fitting opportunity

to rally support for women living with the condition; and

WHEREAS, Premenstrual Dysphoric Disorder is a cyclical

hormone-based mood disorder with mental, emotional, and physical

symptoms that arise each month during the premenstrual phase of the

menstrual cycle; PMDD presents itself one to two weeks before an

individual begins menstruating, and symptoms may include mood

swings, irritability, depression, difficulty focusing, sensitivity

to rejection, changes in appetite, and muscle pain; typically, the

disorder is diagnosed by tracking symptoms on a daily basis for two

or more menstrual cycles; and

WHEREAS, PMDD symptoms can significantly disrupt daily life

and exacerbate mental health issues; many women with PMDD report

experiencing suicidal thoughts during symptomatic times, and the

disorder has led to higher rates of attempted suicide and

self-harm; individuals experiencing the disorder may suffer from

frequently missed workdays, reduced productivity, strained

relationships, career disruption, educational setbacks, and

financial stress from ongoing health care needs; and

WHEREAS, An estimated 115 million women around the globe are

affected by PMDD; like most menstrual disorders, PMDD diagnoses are

very rare and research on the disorder is extremely limited;

although PMDD affects up to five percent of women of childbearing

age in the United States, over half of people with the disorder

experience misdiagnoses or dismissals from providers; due to stigma

surrounding mental health and menstruation, people with PMDD often

suffer in silence and delay care, which increases the risk of

negative outcomes; currently, there are no cures for the disorder,

and it is most commonly managed by the prescription of oral

contraceptives and antidepressant medications as well as through

lifestyle choices; and

WHEREAS, PMDD is a serious and life-changing health issue,

and the observance of Premenstrual Dysphoric Disorder Awareness Day

serves as a means of educating the public and promoting further

research on menstrual and hormone-related mood disorders; now,

therefore, be it

RESOLVED, That the House of Representatives of the 89th Texas

Legislature hereby recognize November 8, 2025, as Premenstrual

Dysphoric Disorder Awareness Day and encourage all Texans to learn

more about PMDD.

Howard

______________________________

Speaker of the House

I certify that H.R. No. 1298 was adopted by the House on May

29, 2025, by a non-record vote.

______________________________

Chief Clerk of the House